This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
| Device | Inspire II Upper Airway Stimulator |
| Generic Name | Stimulator, Hypoglossal Nerve, Implanted, Apnea |
| Applicant | INSPIRE MEDICAL SYSTEMS9700 63rd Avenue Northsuite 200maple Grove, MN 55369 PMA NumberP130008 Supplement NumberS093 Date Received11/18/2022 Decision Date12/16/2022 Product Code MNQ Advisory Committee Anesthesiology Clinical TrialsNCT04457154 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No |
| Date Received | 2022-11-18 |
| Decision Date | 2022-12-16 |
| PMA | P130008 |
| Supplement | S093 |
| Product Code | MNQ |
| Advisory Committee | Anesthesiology |
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | INSPIRE MEDICAL SYSTEMS 9700 63rd Avenue North suite 200 maple Grove, MN 55369 PMA NumberP130008 Supplement NumberS093 Date Received11/18/2022 Decision Date12/16/2022 Product Code MNQ Advisory Committee Anesthesiology Clinical TrialsNCT04457154 Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No Combination ProductNo Approval Order Statement Inspire® Upper Airway Stimulation (UAS) Is Indicated For Use To Treat A Subset Of Patients With Moderate To Severe Obstructive Sleep Apnea (OSA) (apnea-hypopnea Index [AHI] Of Greater Than Or Equal To 15 And Less Than Or Equal To 65). Inspire® UAS Is Used In Adult Patients 22 Years Of Age And Older Who Have Been Confirmed To Fail Or Cannot Tolerate Positive Airway Pressure (PAP) Treatments (such As Continuous Positive Airway Pressure [CPAP] Or Bi-level Positive Airway Pressure [BPAP] Machines) And Who Do Not Have A Complete Concentric Collapse At The Soft Palate Level.PAP Failure Is Defined As An Inability To Eliminate OSA (AHI Of Greater Than 15 Despite PAP Usage), And PAP Intolerance Is Defined As:1) Inability To Use PAP (greater Than 5 Nights Per Week Of Usage; Usage Defined As Greater Than 4 Hours Of Use Per Night), Or2) Unwillingness To Use PAP (for Example, A Patient Returns The PAP System After Attempting To Use It).Inspire® UAS Is Also Indicated For Use In Patients Between The Ages Of 18 And 21with Moderate To Severe OSA (15?AHI?65) Who:• Do Not Have Complete Concentric Collapse At The Soft Palate Level• Are Contraindicated For, Or Not Effectively Treated By, Adenotonsillectomy• Have Been Confirmed To Fail, Or Cannot Tolerate, PAP Therapy Despite Attempts To Improve Compliance• Have Followed Standard Of Care In Considering All Other Alternative/adjunct Therapies |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P130008 | Original Filing | |
| S093 | 2022-11-18 | Normal 180 Day Track No User Fee |
| S092 | ||
| S091 | ||
| S090 | ||
| S089 | ||
| S088 | 2022-07-29 | 30-day Notice |
| S087 | ||
| S086 | ||
| S085 | ||
| S084 | 2022-05-20 | 30-day Notice |
| S083 | 2022-03-15 | 30-day Notice |
| S082 | 2022-03-02 | 30-day Notice |
| S081 | 2022-02-17 | 30-day Notice |
| S080 | 2022-02-17 | 30-day Notice |
| S079 | 2022-02-11 | 30-day Notice |
| S078 | 2022-01-26 | 30-day Notice |
| S077 | 2022-01-05 | 30-day Notice |
| S076 | ||
| S075 | 2021-10-07 | 30-day Notice |
| S074 | ||
| S073 | 2021-08-13 | Normal 180 Day Track No User Fee |
| S072 | ||
| S071 | 2021-07-13 | 30-day Notice |
| S070 | ||
| S069 | ||
| S068 | ||
| S067 | 2021-05-25 | 30-day Notice |
| S066 | 2021-05-14 | 30-day Notice |
| S065 | ||
| S064 | 2021-03-12 | 30-day Notice |
| S063 | 2020-12-14 | Normal 180 Day Track |
| S062 | 2020-09-14 | 30-day Notice |
| S061 | ||
| S060 | 2020-08-31 | 30-day Notice |
| S059 | 2020-08-26 | 30-day Notice |
| S058 | 2020-08-20 | 30-day Notice |
| S057 | ||
| S056 | ||
| S055 | ||
| S054 | 2020-06-25 | 30-day Notice |
| S053 | 2020-05-19 | 30-day Notice |
| S052 | 2020-05-14 | Normal 180 Day Track No User Fee |
| S051 | 2020-01-31 | 30-day Notice |
| S050 | ||
| S049 | 2019-12-17 | Special (immediate Track) |
| S048 | 2019-12-12 | 30-day Notice |
| S047 | ||
| S046 | 2019-08-16 | 30-day Notice |
| S045 | 2019-06-24 | 30-day Notice |
| S044 | 2019-05-23 | 30-day Notice |
| S043 | ||
| S042 | ||
| S041 | 2019-04-23 | Real-time Process |
| S040 | 2019-01-29 | 30-day Notice |
| S039 | ||
| S038 | 2018-12-11 | 30-day Notice |
| S037 | 2018-10-26 | Real-time Process |
| S036 | 2018-10-15 | 30-day Notice |
| S035 | 2018-08-16 | 30-day Notice |
| S034 | 2018-04-16 | Normal 180 Day Track |
| S033 | 2018-02-14 | Real-time Process |
| S032 | 2018-02-05 | 30-day Notice |
| S031 | 2017-12-13 | Normal 180 Day Track |
| S030 | ||
| S029 | 2017-11-14 | Normal 180 Day Track No User Fee |
| S028 | 2017-11-08 | 30-day Notice |
| S027 | 2017-10-13 | 30-day Notice |
| S026 | 2017-05-09 | 30-day Notice |
| S025 | 2017-05-08 | 30-day Notice |
| S024 | 2017-05-08 | 30-day Notice |
| S023 | 2017-05-04 | Real-time Process |
| S022 | 2017-03-29 | Normal 180 Day Track No User Fee |
| S021 | 2017-03-29 | Normal 180 Day Track |
| S020 | 2017-01-23 | Normal 180 Day Track |
| S019 | 2016-12-08 | 30-day Notice |
| S018 | 2016-11-23 | 30-day Notice |
| S017 | 2016-11-17 | 30-day Notice |
| S016 | 2016-10-06 | Normal 180 Day Track |
| S015 | 2016-09-14 | 30-day Notice |
| S014 | 2016-07-05 | 30-day Notice |
| S013 | 2016-05-05 | Normal 180 Day Track |
| S012 | 2016-04-22 | 30-day Notice |
| S011 | 2016-04-08 | 30-day Notice |
| S010 | 2016-03-30 | Normal 180 Day Track No User Fee |
| S009 | 2015-11-12 | Normal 180 Day Track |
| S008 | 2015-05-27 | Real-time Process |
| S007 | 2015-03-25 | 30-day Notice |
| S006 | 2015-03-03 | 30-day Notice |
| S005 | 2015-01-28 | 30-day Notice |
| S004 | 2014-10-07 | 30-day Notice |
| S003 | 2014-07-23 | Normal 180 Day Track No User Fee |
| S002 | 2014-06-30 | Normal 180 Day Track |
| S001 | 2014-05-12 | 30-day Notice |